What the trials monitored, and what that implies about routine practice
Timing is the whole of the post-cessation panel: draw it too early and it measures the treatment period.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 9 of 12 of this archive, newest first.
Timing is the whole of the post-cessation panel: draw it too early and it measures the treatment period.
Timing is the whole of the post-cessation panel: draw it too early and it measures the treatment period.
Every instrument specification quoted in an advertisement is a best case obtained on a calibration mixture, not on a submitted vial.
Column chemistry, particle size and pore diameter determine what the separation is capable of before the gradient is even programmed.
We asked all four services what they can determine, on what timescale, at what price, and under what accreditation. The answers are printed in full.
The ionisation method determines the charge states you see, the adducts you must account for, and the modifications you might destroy in the process.
A shallow gradient resolves impurities that a steep one runs into the parent peak. Both methods are legitimate; only one of them can see the small stuff.
What the pivotal programmes measured and how often, which is a more defensible template than most published monitoring schedules.
Lyophilisation does not stop degradation. It slows every pathway by removing the solvent that most of them require, and the residue of solvent that remains sets the rate.
Storage instructions in this market are close to uniform and almost never accompanied by the study that would justify them. Uniformity is a sign of convention, not of…
The arithmetic of the reference change value, worked for the analytes that matter here.
The sequence predicts the failure mode. A methionine predicts oxidation; an asparagine followed by a glycine predicts deamidation; a cysteine predicts disulphide scrambling.
Gauge affects pain and flow rate rather than depth. A finer needle is more comfortable and slower, and with a viscous solution the difference is noticeable.
Lyophilisation does not stop degradation. It slows every pathway by removing the solvent that most of them require, and the residue of solvent that remains sets the rate.
The recommendation survives scrutiny. The reasoning offered for it frequently does not.
The practical difficulty is not knowing the target. It is meeting it on an appetite that has been pharmacologically reduced by half.
Three different explanations for the same abnormal number, and how to tell them apart.
What the renal and hepatic outcome programmes actually measured, and over what duration.
Particulate matter is the oldest quality attribute in injectable manufacture and the one a private buyer is best placed to assess without instrumentation.
The insulin injection-technique literature is large, well conducted and directly transferable on questions of depth and tissue. We say where it stops transferring.